Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VITALITY BIOPHARMA, INC.

(VBIO)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

VITALITY BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

06/22/2021 | 09:02am EDT
Item 8.01 Other Events.




CEO Letter to Shareholders


On June 21, 2021, Vitality Biopharma, Inc. (the "Company") posted on the Company's website (www.vitality.bio) a letter from the Company's Chief Executive Officer, Michael Cavanaugh, to the Company's shareholders. A copy of the letter is filed as Exhibit 20.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits




Exhibit No.   Description

20.1            Letter from Michael Cavanaugh to the Company's Shareholders

© Edgar Online, source Glimpses

All news about VITALITY BIOPHARMA, INC.
09/02Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eli..
GL
09/02VITALITY BIOPHARMA : ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIG..
PU
09/02VITALITY BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form..
AQ
08/23VITALITY BIOPHARMA : Enters into $5 million equity financing relationship with i..
AQ
08/20VITALITY BIOPHARMA : ENTERS INTO $5 MILLION EQUITY LINE FINANCING RELATIONSHIP W..
PU
08/20VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Other Eve..
AQ
08/20Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship ..
GL
08/19Vitality Biopharma, Inc. announced that it expects to receive $5 million in f..
CI
08/13VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition..
AQ
08/13Vitality Biopharma, Inc. Reports Earnings Results for the First Quarter Ended..
CI
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -0,88 M - -
Net cash 2021 0,85 M - -
P/E ratio 2021 -10,4x
Yield 2021 -
Capitalization 21,0 M 21,0 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 3
Free-Float 66,4%
Chart VITALITY BIOPHARMA, INC.
Duration : Period :
Vitality Biopharma, Inc. Technical Analysis Chart | VBIO | US92849B1070 | MarketScreener
Income Statement Evolution
Managers and Directors
Michael Cavanaugh Chief Executive Officer & Director
Richard McKilligan Controller, Chief Financial & Accounting Officer
Edward F. Feighan Executive Chairman
Brandon Zipp Chief Science Officer
Richard F. Celeste Independent Director
Sector and Competitors
1st jan.Capi. (M$)
VITALITY BIOPHARMA, INC.600.00%21
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
REGENERON PHARMACEUTICALS34.93%67 775
WUXI APPTEC CO., LTD.35.75%60 418
VERTEX PHARMACEUTICALS-20.33%48 850